News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
GENSCRIPT BIOTECH (01548.HK) 1Q26 CARVYKTI Net Sales USD597M, Up 61.8% YoY
GENSCRIPT BIOTECH (01548.HK) announced that its subsidiary Legend Biotech, pursuant to its collaboration and license agreement with Janssen Biotech, recorded net trade sales of app...
Reset
Send
The window will close in 5 seconds
GENSCRIPT BIOTECH (01548.HK) 1Q26 CARVYKTI Net Sales USD597M, Up 61.8% YoY
Close
Recommend
3
Positive
3
Negative
4
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

GENSCRIPT BIOTECH (01548.HK)  +0.010 (+0.073%)    Short selling $20.83M; Ratio 17.934%   announced that its subsidiary Legend Biotech, pursuant to its collaboration and license agreement with Janssen Biotech, recorded net trade sales of approximately USD597 million for CARVYKTI in 1Q26, representing a YoY increase of 61.8%. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-17 16:25.)



This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI
View Original Text

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.